Wimalawansa Sunil J
Department of Medicine, Endocrinology & Human Nutrition, North Brunswick, NJ, United States.
Nutr Rev. 2025 Feb 10. doi: 10.1093/nutrit/nuae164.
This systematic review (SR) highlights principles for nutrient clinical trials and explore the diverse physiological functions of vitamin D beyond its traditional role in the musculoskeletal system related to clinical study designs.
Thousands of published research articles have investigated the benefits of vitamin D (a nutrient example taken in this SR) beyond the musculoskeletal system, including the immune, pulmonary, and cardiovascular systems; pregnancy; autoimmune disorders; and cancer. They illustrated vitamin D's molecular mechanisms, interactions, and genomic and nongenomic actions.
This SR was designed to identify shortcomings in clinical study designs, statistical methods, and data interpretation that led to inconsistent findings in vitamin D-related publications. SR also highlights examples and insights into avoiding study design errors in future clinical studies, including randomized controlled clinical trials (RCTs). The SR adheres to the latest PRISMA statement, guidelines, and the PICOS process.
Inappropriate or flawed study designs were frequent in clinical trials. Major failures discussed here include too short clinical study duration, inadequate or infrequent doses, insufficient statistical power, failure to measure baseline and achieved levels, and recruiting vitamin D-sufficient participants. These design errors have led to misleading interpretations. Thus, conclusions from such studies should not be generalized or used in guidelines, recommendations, or policymaking.
Adequately powered epidemiological studies and RCTs with sufficient vitamin D and duration in individuals with vitamin D deficiency reported favorable clinical outcomes, enriching the literature, enabling to understand its physiology and mechanisms. Proper study designs with rigorous methodologies and cautious interpretation of outcomes are crucial in advancing the nutrient field. The principles discussed apply not only to vitamin D, but also other micro-nutrients and nutraceutical research. Adhering to them enhances the credibility and reliability of clinical trials, SRs, and meta-analysis outcomes. The study emphasizes the importance of focused, hypothesis-driven, well-designed, statistically powered RCTs to explore the diverse benefits of nutrients, conducted in index nutrient deficient participants, and avoidance of study design errors. Findings from such studies should be incorporated into clinical practice, policymaking, and public health guidelines, improving the health of the nation and reducing healthcare costs.
本系统评价(SR)强调营养临床试验的原则,并探讨维生素D在骨骼肌肉系统之外的多种生理功能,这些功能与临床研究设计相关。
数千篇已发表的研究文章探讨了维生素D(本SR中选取的一种营养物质实例)在骨骼肌肉系统之外的益处,包括免疫、肺和心血管系统;妊娠;自身免疫性疾病;以及癌症。这些研究阐述了维生素D的分子机制、相互作用以及基因组和非基因组作用。
本SR旨在识别临床研究设计、统计方法和数据解释方面的缺陷,这些缺陷导致了维生素D相关出版物中的结果不一致。SR还强调了在未来临床研究中避免研究设计错误的实例和见解,包括随机对照临床试验(RCT)。该SR遵循最新的PRISMA声明、指南和PICOS流程。
临床试验中经常出现不恰当或有缺陷的研究设计。此处讨论的主要失败包括临床研究持续时间过短、剂量不足或不频繁、统计效力不足、未测量基线水平和达到的水平,以及招募维生素D充足的参与者。这些设计错误导致了误导性的解释。因此,此类研究的结论不应被推广或用于指南、建议或政策制定。
在维生素D缺乏的个体中进行的、有足够效力的流行病学研究和RCT,给予足够的维生素D并持续足够的时间,报告了良好的临床结果,丰富了文献,有助于理解其生理学和机制。采用严谨方法的恰当研究设计以及对结果的谨慎解释对于推动营养领域的发展至关重要。所讨论的原则不仅适用于维生素D,也适用于其他微量营养素和营养保健品研究。遵循这些原则可提高临床试验、SR和荟萃分析结果的可信度和可靠性。该研究强调了聚焦的、假设驱动的、设计良好且有统计效力的RCT的重要性,以探索营养素的多种益处,这些研究应在缺乏目标营养素的参与者中进行,并避免研究设计错误。此类研究的结果应纳入临床实践、政策制定和公共卫生指南,以改善国民健康并降低医疗成本。